Latest Industry Insights

Industry Insight
The Role of Automation in Industrializing Cell Therapy Manufacturing
Technology Networks spoke to Dr. Dan Strange, CTO at Cellular Origins, to discuss how integrating proven tools and technologies, such as automation, helps cell therapy companies scale up production.

Industry Insight
Cutting Biotherapeutic Development Timelines With Advanced Microfluidics
In this interview, Dr. Graeme Daniels, Sphere Fluidics, shares how advanced microfluidics are set to revolutionize biotherapeutic workflows and discusses the technology's future potential in broader applications, including cell and gene therapy.

Industry Insight
Biotech Start-Ups Share How They Are Addressing Key Limitations in Disease Models
Technology Networks asked a selection of start-up companies at ELRIG Drug Discovery how their technology addresses key limitations in traditional disease models.

Industry Insight
Getting New Drug Modalities to Market: How Can Your Data Strategy Help?
This article explores the revolution in new drug modalities and the challenges around effective data strategies to support AI efforts.

Industry Insight
Innovation Award Winner Announced at ELRIG Drug Discovery 2024
Technology Networks had the pleasure of speaking with the ELRIG Innovation Award Winner Constructive Bio’s CEO, Dr. Ola Wlodek, to discuss its award-winning innovations and learn more about its mission.

Industry Insight
Next-Generation Solutions for Discovery Omics
Learn from James Hallam, vice president of the Research, Development and Advanced Testing Business segment at Waters Corporation, about how technological advancements in mass spectrometry are powering new discoveries in omics research.

Industry Insight
Overcoming Challenges in Bioanalysis With Artificial Intelligence
In bioanalysis, AI could alleviate preclinical and clinical bioanalytical data processing and analysis. Here, Mary Belfast from Teva Branded Pharmaceuticals, discusses some of the latest guidelines on AI implementation and validation in bioanalysis.

Industry Insight
After MDMA’s FDA Approval Setback, Science Must Lead the Way
Dr. Sergio Pérez Rosal explains why, in his opinion, “hope is not lost” and the therapeutic potential of psychedelics for the treatment of psychiatric disorders could still be unlocked. But what happens next must be firmly rooted in science.

Industry Insight
Understanding Doping Control in Sports: An Interview With Professor Peter Van Eenoo
We sat down with Professor Peter Van Eenoo, director of the Doping Control Laboratory (DoCoLab), part of the University of Ghent, Belgium, to discuss the intricacies of anti-doping testing and the challenges faced in catching sporting cheats.

Industry Insight
Harnessing AI and Automation for the Future of Drug Discovery
In this interview, Tola Olorunnisola, senior vice president and general manager at Avantor, delves into how AI and automation could put the Lab of the Future within our grasp, enabling scientific breakthroughs and revolutionizing the drug development process.
Advertisement